HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Katagiri Selected Research

Cholangiocarcinoma

3/2022Intrahepatic Cholangiocarcinoma With Neither Intrahepatic Metastasis Nor Lymph Node Metastasis Is the Optimal Indication for Hepatectomy With Adjuvant Therapy.
6/2014Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy.
5/2012Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor.
8/2011Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Katagiri Research Topics

Disease

20Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2003
16Neoplasms (Cancer)
12/2020 - 08/2004
4Cholangiocarcinoma
03/2022 - 08/2011
4Neoplasm Metastasis (Metastasis)
03/2022 - 07/2011
3Macular Degeneration (Age-Related Maculopathy)
01/2021 - 01/2019
3Disease Progression
12/2020 - 01/2018
3Atrophy
01/2020 - 01/2019
3Retinoschisis (Retinoschisis, Juvenile)
01/2019 - 04/2017
3Hemorrhage
06/2015 - 01/2004
2Lymphatic Metastasis
03/2022 - 08/2004
2Retinal Detachment (Retinal Detachments)
11/2021 - 01/2021
2Cataract (Cataracts)
01/2021 - 07/2013
2Photophobia (Light Sensitivity)
01/2021 - 01/2020
2Ocular Paraneoplastic Syndromes
12/2020 - 12/2019
2Cone-Rod Dystrophies
01/2020 - 01/2019
2Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2019 - 01/2014
2Ganglion Cysts (Ganglion)
04/2017 - 11/2016
2Familial Exudative Vitreoretinopathies
03/2016 - 01/2016
1Ischemia
11/2021
1Retinopathy of Prematurity (Retrolental Fibroplasia)
11/2021
1Stomach Neoplasms (Stomach Cancer)
07/2021
1Hyperplasia
01/2021
1Coloboma (Colobomas)
01/2021
1Hypotrichosis
01/2021
1Endometrial Neoplasms (Endometrial Cancer)
12/2020
1Blindness (Hysterical Blindness)
12/2020
1Retinal Degeneration
12/2020
1Thymoma (Thymic Carcinoma)
10/2020
1Leber Congenital Amaurosis
01/2020
1Night Blindness (Nyctalopia)
01/2020
1congenital stationary Night blindness
01/2020
1Ductal Carcinoma
12/2019
1Adenocarcinoma
12/2019
1Breast Neoplasms (Breast Cancer)
12/2019
1Cysts
03/2019
1Choroideremia
01/2019
1Retinal Perforations
01/2018
1Glaucoma
05/2017
1Optic Nerve Hypoplasia
01/2017
1Congenital Abnormalities (Deformity)
11/2016
1Aniridia
11/2016
1Surgical Wound
10/2015
1Ataxia (Dyssynergia)
06/2015
1Hypoventilation
06/2015
1Intraoperative Complications
06/2015
1White Dot Syndromes
03/2015
1Chronic Thyroiditis
03/2015
1Carcinoma (Carcinomatosis)
06/2014
1Thrombosis (Thrombus)
02/2014

Drug/Important Bio-Agent (IBA)

22Retinaldehyde (Retinal)IBA
11/2021 - 01/2016
3gadolinium ethoxybenzyl DTPAFDA Link
12/2020 - 07/2011
2SteroidsIBA
12/2020 - 01/2018
2SonazoidIBA
10/2020 - 04/2018
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
07/2013 - 03/2013
2InterferonsIBA
06/2008 - 01/2003
2Ethiodized Oil (Ethiodol)FDA Link
11/2007 - 09/2007
2EmulsionsIBA
11/2007 - 09/2007
2LecithinsIBA
11/2007 - 09/2007
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
08/2004 - 03/2004
1Fluorescein (Funduscein)FDA LinkGeneric
11/2021
1Bevacizumab (Avastin)FDA Link
11/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2021
1Retinal Pigments (Pigments, Visual)IBA
01/2021
1Cadherins (E-Cadherin)IBA
01/2021
1Prednisolone (Predate)FDA LinkGeneric
12/2020
1TransducinIBA
01/2020
1Pregabalin (Lyrica)FDA Link
01/2020
1PlatinumIBA
12/2019
1folfirinoxIBA
12/2019
1AutoantibodiesIBA
12/2019
1Transient Receptor Potential ChannelsIBA
12/2019
1Antiviral Agents (Antivirals)IBA
02/2019
1GTP Phosphohydrolases (GTPases)IBA
01/2019
1Prothrombin (Factor II)IBA
04/2018
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
07/2017
1Thymidylate SynthaseIBA
07/2017
1Explosive Agents (Explosives)IBA
06/2015
1Rhodopsin (Visual Purple)IBA
01/2014

Therapy/Procedure

19Hepatectomy
03/2022 - 01/2004
8Therapeutics
03/2022 - 01/2003
3Drug Therapy (Chemotherapy)
07/2021 - 09/2007
3Anesthesia
01/2021 - 11/2012
2Adjuvant Chemotherapy
03/2022 - 12/2020
2Vitrectomy
11/2021 - 07/2013
2General Anesthesia
01/2021 - 11/2012
1Immunotherapy
03/2022
1Light Coagulation
11/2021
1Injections
11/2021
1Lasers (Laser)
11/2021
1Neoadjuvant Therapy
07/2021
1Gastrectomy
07/2021
1Local Anesthesia
01/2021
1Traction
01/2021
1Thymectomy
10/2020
1Liver Transplantation
02/2019
1Scleral Buckling
01/2018
1Trabeculectomy (Trabeculoplasty)
05/2017
1Intraocular Lenses (Intraocular Lens)
10/2015
1Splenectomy
03/2015
1Transjugular Intrahepatic Portasystemic Shunt
08/2014